Ann: 1H FY22 Results - Webcast Recording, page-175

First 175 Last

Share
Profile

Follow
bobgr

76 Posts.

9

07/03/22

13:09

Post #: 60030872
Share

Originally posted by gavncath: ↑

Dear Polynovians,

I mostly don't post on PNV threads as the banter is mind numbing. I've held PNV shares since 2005 (or the entity at the time that owned PNV early on). Despite the 'ups and downs' I'm a happy-ish holder.

Am I disappointed that since BTM was developed there has not been a second product such as hernia device developed/approved? Absolutely.

Am I disappointed that the sales traction for BTM hasn't hit what I thought it would for such a market disruptive product? Absolutely.

Why do I remain a happy-ish holder? Because the BTM product is sensational. It saves lives. It improves quality of life. It gets minimal infection and saves hospital time and money. The opportunity is huge. The margins are ridiculous.

What would I like to see? A few things. PNV is currently trying to do everything from R&D/manufacturing and extending through to hospital sales... a massive ask for a small company in worldwide markets. I'd love to see PNV recognise their core skill was (and should be) a R&D company. Yes distributors take a margin but margins are huge anyway. Distributors have sales people on the ground and know the market they sell into... I'd love to see that change worldwide. I'd then like the appointment of a CEO with R&D/Manufacturing/regulatory experience... ditch the sales, leave that to experts that have that as their core business. Novosorb is a sensational biodegradable substance, it can be 3D printed, the potential medical uses are endless... R&D investment returns will be offensively large. These thoughts take me back to the book "Good to Great" by Jim Collins... I think the board needs to consider what the "Core skill" PNV has and get laser focussed on that.

I'd also love to see is PNV putting some effort into investor relations... :-(

My final comment is on share price... wow. Sub $1 is astounding. I've just bought myself another wedge of shares at 98cents this morning. Dead cheap. The shorters have provided a sensational opportunity to buy up again... I really feel for holders who need to sell at these stupidly low prices!

Stay well.

Gav

Expand

Hi Gav
The direct sales approach is working well in USA.
The distributor model in Europe is very disappointing.
One thing I have learned is you want something done well, do it yourself.
At this stage of infancy PNV need to be in control.
Bob

PNV Price at posting: 96.0¢ Sentiment: Buy Disclosure: Held
18 Upvote

2 Great analysis

Reply

Top Stories

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

What's causing the cost-of-living crisis, and how to navigate it

M4M

Macro, Norden set up transport solutions initiative for West Pilbara